Conatus Pharmaceuticals Inc. (CNAT) jumped 10.86% or 0.19 to $1.94. It is approximately 603153 shares traded, which is 55.62% compare to the average total volume 1.08 million. The market cap of CNAT is $64.30 million. The year to date change is 7.54%. The 52 week price range is from $1.15 to $7.95. Price of CNAT have changed 35.66% during last week. It have changed -62.37% over last month, -67.53% over last 3 months, -61.45% over last 6 months and -63.39% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNAT is 3.53. It is 81.96% above current price. The 200-day Moving Averages for CNAT is 4.31. It is 122.16% above current price. The 52-week High is 7.95. It is 309.79% from the current price. The 52-week Low is 1.15. It is -40.72% from current price.
There are some statistics of CNAT. It is has market cap $64.30 million. The share outstanding is 33.14 million. The average volume is 1.08 million. The percent of top 15 Institution holding is 40.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNAT is -77.60%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNAT is -25.20%.